comparemela.com

Incannex Healthcare (IXHL) Receives HREC Approval for Phase 2 Clinical Trial of IHL-675A

Incannex Healthcare (IXHL) Receives HREC Approval for Phase 2 Clinical Trial of IHL-675A
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Camberwell ,Victoria ,Australia ,United States ,Sydney ,New South Wales ,Melbourne ,New Zealand ,Australian ,American ,Mark Bleackley ,Sullivan Asia Pacific ,Limitedmr Joel Lathammanaging ,Incannex Healthcare Limited Nasdaq ,Nasdaq ,Bellberry Human Research Ethics Committee ,United Statesalyssa Factoredison Group ,Australian Stock Exchange ,Oracle ,Incannex Healthcare ,Incannex Healthcare Limited ,Emeritus Research ,Active Pharmaceutical Ingredients ,Avance Clinical ,Patient Reported Outcomes ,Chief Scientific Officer Dr Mark Bleackley ,New South ,All Emeritus Research ,North American ,Leadership Award ,Incannex Board ,American Depository Shares ,Securities Litigation Reform Act ,Healthcare Limitedmr Joel Lathammanaging Director ,Chief Executive ,Relations Contact ,United Statesalyssa Factoredison ,

comparemela.com © 2020. All Rights Reserved.